PAUL COLEMAN: Open Payments
NPI 1417537671 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 87 payments from 27 companies in 2025. Trend: 2023 $1,447 · 2024 $1,390 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $227 |
| Axsome Therapeutics, Inc. | 8 | $178 |
| Eisai Inc. | 2 | $144 |
| Lundbeck LLC | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| PFIZER INC. | 5 | $92 |
| GlaxoSmithKline, LLC. | 4 | $87 |
| Sumitomo Pharma America, Inc. | 5 | $80 |
| Lilly USA, LLC | 4 | $76 |
| Exact Sciences Corporation | 4 | $73 |
Products named: REXULTI, Auvelity, VRAYLAR, Leqembi, TRELEGY ELLIPTA, GEMTESA, Cologuard Collection Kit, QULIPTA.
Industry payments across TX — which companies pay providers there.
